SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-199672
Filing Date
2018-06-21
Accepted
2018-06-21 17:21:22
Documents
4
Effectiveness Date
2018-06-21

Document Format Files

Seq Description Document Type Size
1 S-8 d621185ds8.htm S-8 59476
2 EX-5.1 d621185dex51.htm EX-5.1 8688
3 EX-23.2 d621185dex232.htm EX-23.2 1619
4 GRAPHIC g621185g31v35.jpg GRAPHIC 3264
  Complete submission text file 0001193125-18-199672.txt   75493
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-225799 | Film No.: 18912540
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences